COMMODORE CAPITAL LP enters AMBRX BIOPHARMA CAYMAN, INC. with 35.70M shares across direct and indirect positions
This filing by COMMODORE CAPITAL LP establishes the baseline for all future Form 4 insider transaction reports at AMBRX BIOPHARMA CAYMAN, INC..
Indirect
Filed: 3/3/2023ACC: 0001493152-23-006669
10% Owner
Since Feb 2023
35.70M
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
1
Security positions
35.70M indirect
Non-Derivative Holdings1
Ordinary Shares
IndirectShares owned35.70M
Total
35.70M indirect35.70M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 35.70M | Indirect |
| Total | 35.70M | 35.70M indirect |
Derivative Holdings0
No derivative holdings reported